New Flu Strain Circulated Globally, Prompting Vaccine Updates
Translated & summarized from Israel Hayom by baba
A new influenza A(H3N2) subtype, Subclade K, rapidly spread globally and became dominant in Israel during the 2025-2026 season, prompting an updated flu vaccine for 2026-2027. Last winter, Israel recorded 4,458 flu hospitalizations, including 178 deaths within 30 days of diagnosis. Experts advise annual vaccination due to the virus's constant mutation, recommending it especially for high-risk groups like the elderly and young children. While the new strain's impact on the upcoming winter is uncertain, preparedness is key.
The story in 6 lines · by baba
- A new flu subtype, Subclade K of A(H3N2), became globally dominant in the 2025-2026 season, necessitating a vaccine update.
- Israel saw 4,458 flu hospitalizations last winter, with 178 deaths recorded within 30 days of diagnosis.
- The World Health Organization recommended a new H3N2 vaccine component for the 2026-2027 season.
- Annual flu vaccination is crucial as the virus constantly changes, requiring updated protection.
- High-risk groups, including the elderly and young children, are particularly vulnerable to flu complications.
- The severity of the upcoming winter flu season remains uncertain despite the new dominant strain.
A new subtype of the influenza A(H3N2) virus, designated Subclade K, rapidly spread worldwide during the 2025-2026 season, becoming dominant in many countries, including Israel. This evolution necessitated an update to the flu vaccine for the upcoming 2026-2027 season, with the World Health Organization recommending a new H3N2 component in February 2026 to better match circulating strains.
Last winter's flu season in Israel saw 4,458 hospitalizations due to confirmed influenza cases across 14 general hospitals, with 1,905 of those patients aged 65 and older. Within 30 days of diagnosis, 178 deaths were recorded among hospitalized flu patients, though the Ministry of Health noted this figure indicates deaths during the period, not necessarily solely caused by the flu. The mortality rate was particularly high among the elderly.
Dr. Adam Reiter, a family medicine specialist, emphasized that flu symptoms can vary, being mild in healthy individuals but potentially severe in those at risk. He highlighted the importance of monitoring overall condition and disease progression. The emergence of Subclade K, with its distinct genetic changes, underscores why flu viruses necessitate annual vaccine reformulation.
While the spread of Subclade K was significant, experts caution that it does not definitively predict a harsher upcoming winter season. The World Health Organization has not stated that the new strain inherently causes more severe illness. However, the rapid spread and identification of the change allowed for timely vaccine adjustments.
Annual vaccination is recommended because the constantly evolving flu virus requires updated vaccines each season. Dr. Reiter advises that even those vaccinated last season should receive the current year's vaccine for optimal protection against anticipated strains. The Ministry of Health recommends vaccination before winter, preferably in the autumn, especially for individuals at higher risk of complications.
High-risk groups include infants and young children, individuals aged 65 and above, pregnant women, and those with chronic illnesses or weakened immune systems. Young children, particularly those with underlying conditions, face an increased risk of complications like pneumonia. Prompt medical consultation is advised for these individuals if symptoms worsen.
Distinguishing flu from other respiratory illnesses can be challenging, but flu often presents with a more abrupt onset, including fever, chills, muscle aches, headache, significant weakness, and cough. Seek medical attention for symptoms like shortness of breath, chest pain, confusion, dehydration, unusual weakness, persistent high fever, or a pattern of improvement followed by worsening, as these could indicate complications or worsening of existing conditions.
Antiviral medications may be prescribed in certain cases, particularly for high-risk individuals, severely ill patients, or those hospitalized. Early initiation of treatment is crucial. Dr. Reiter concluded that while the exact severity of the upcoming flu season remains uncertain, preparedness through timely vaccination, attention to at-risk populations, and awareness of warning signs can help mitigate risks and complications.
Mentioned
